Literature DB >> 27016528

Widely Used Types and Clinical Applications of D-Dimer Assay.

Roger S Riley1, Andrea R Gilbert2, Justin B Dalton3, Sheela Pai4, Richard A McPherson3.   

Abstract

D-dimers are formed by the breakdown of fibrinogen and fibrin during fibrinolysis. D-dimer analysis is critical for the diagnosis of deep vein thrombosis, pulmonary embolism, and disseminated intravascular coagulation. Modern assays for D-dimer are monoclonal antibody based. The enzyme-linked immunosorbent assay (ELISA) is the reference method for D-dimer analysis in the central clinical laboratory, but is time consuming to perform. Recently, a number of rapid, point-of-care D-dimer assays have been developed for acute care settings that utilize a variety of methodologies. In view of the diversity of D-dimer assays used in central laboratory and point-of-care settings, several caveats must be taken to assure the proper interpretation and clinical application of the results. These include consideration of preanalytical variables and interfering substances, as well as patient drug therapy and underlying disease. D-dimer assays should also be validated in clinical studies, have established cut-off values, and reported according to the reagent manufacturers recommendations. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  D-dimer testing; blood coagulation; cancer; chemiluminescent immunoassay; coronary artery disease; disseminated intravascular coagulation; fibrinogen degradation products; heart disease; immunoassay; point-of-care testing; pulmonary embolism; venous thromboembolism; venous thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27016528     DOI: 10.1093/labmed/lmw001

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  21 in total

1.  What makes D-dimer assays suspicious-heterophilic antibodies?

Authors:  Ying Wu; Ying-Xiu Xiao; Teng-Yi Huang; Xian-Yan Zhang; Huan-Bing Zhou; Xue-Xuan Zhang; Ying-E Wu
Journal:  J Clin Lab Anal       Date:  2018-10-15       Impact factor: 2.352

Review 2.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

3.  D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE Registry.

Authors:  Maki Oi; Yugo Yamashita; Mamoru Toyofuku; Takeshi Morimoto; Yasuyo Motohashi; Takashi Tamura; Kazuaki Kaitani; Hidewo Amano; Toru Takase; Seiichi Hiramori; Kitae Kim; Masaharu Akao; Yohei Kobayashi; Tomohisa Tada; Po-Min Chen; Koichiro Murata; Yoshiaki Tsuyuki; Syunsuke Saga; Tomoki Sasa; Jiro Sakamoto; Minako Kinoshita; Kiyonori Togi; Hiroshi Mabuchi; Kensuke Takabayashi; Hiroki Shiomi; Takao Kato; Takeru Makiyama; Koh Ono; Takeshi Kimura
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

4.  Update from the clinic: what's new in the diagnosis of cancer-associated thrombosis?

Authors:  Erica A Peterson; Agnes Y Y Lee
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 5.  Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.

Authors:  Rahnuma Ahmad; Mainul Haque
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 6.  Pulmonary Embolism for the Cardiologist: Emphasis on Diagnosis.

Authors:  Jonathan Halevy; Mary Cushman
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

7.  A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects.

Authors:  Yubin Liu; Meixia Wang; Xiaona Dong; Jia He; Lin Zhang; Ying Zhou; Xia Xia; Guifang Dou; Chu-Tse Wu; Jide Jin
Journal:  Pharmacol Res Perspect       Date:  2021-05

8.  Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran-Results of the phase 1 inhibitor cohort.

Authors:  K John Pasi; Toshko Lissitchkov; Vasily Mamonov; Tim Mant; Margarita Timofeeva; Catherine Bagot; Pratima Chowdary; Pencho Georgiev; Liana Gercheva-Kyuchukova; Kate Madigan; Huy Van Nguyen; Qifeng Yu; Baisong Mei; Craig C Benson; Margaret V Ragni
Journal:  J Thromb Haemost       Date:  2021-05-18       Impact factor: 5.824

9.  Machine learning-based diagnosis for disseminated intravascular coagulation (DIC): Development, external validation, and comparison to scoring systems.

Authors:  Jihoon G Yoon; JoonNyung Heo; Minkyu Kim; Yu Jin Park; Min Hyuk Choi; Jaewoo Song; Kangsan Wyi; Hakbeen Kim; Olivier Duchenne; Soowon Eom; Yury Tsoy
Journal:  PLoS One       Date:  2018-05-02       Impact factor: 3.240

10.  The clinical significance of ultra-high D-dimer levels.

Authors:  Kristin Schafer; Eric Goldschmidt; Drew Oostra; John Fish; Todd Russell; Fedor Lurie
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.